May 31, 2008Mycophenolate Mofetil (marketed as CellCept) and Mycophenolic Acid (marketed as Myfortic) Mycophenolate Mofetil (marketed as CellCept) and Mycophenolic Acid (marketed as Myfortic)
FDA issues an FDA Alert and Information for Healthcare Professional sheet for Mycophenolate Mofetil (MMF) and Mycophenolic Acid (MPA). Current Drug Shortage: Neupro (rotigotine transdermal system) UCB is preparing to recall all Neupro lots in the U.S. by May 2008 FDA Advises Patients to Switch to HFA-Propelled Albuterol Inhalers Now CFC-propelled albuterol inhalers are being phased out because they are harmful to the environment by contributing to depletion of the ozone layer above the Earth's surface. FDA Embarks on Major Hiring Initiative for its Public Health Mission The FDA is hiring hundreds of individuals with science and medical backgrounds to help meet the agency's responsibilities to assure the safety and/or efficacy of human and veterinary drugs, biological products, medical devices, food, cosmetics and products that emit radiation. # posted by Network @ 10:03 AM
 |
Subscribe to Posts [Atom]